Shoreline, WA, United States of America

Jeffrey A Ledbetter

USPTO Granted Patents = 81 

 

 

Average Co-Inventor Count = 3.3

ph-index = 36

Forward Citations = 4,488(Granted Patents)


Inventors with similar research interests:


Location History:

  • Shorline, WA (US) (2014)
  • Seattle, WA (US) (1987 - 2022)
  • Shoreline, WA (US) (2006 - 2022)

Company Filing History:

goldMedal37 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal11 out of 2,099 
 
University of Washington
 patents
bronzeMedal8 out of 11 
 
Emergent Product Development Seattle,llc
 patents
44 out of 5 
 
Trubion Pharmaceuticals, Inc.
 patents
54 out of 4 
 
Theripion, Inc.
 patents
63 out of 142 
 
Xoma Corporation
 patents
72 out of 2 
 
Royalty Pharma Finance Trust
 patents
82 out of 662 
 
Dartmouth College
 patents
92 out of 48 
 
Oncogen
 patents
102 out of 9 
 
Pacific Northwest Research Institute
 patents
112 out of 12 
 
Aptevo Research and Development LLC
 patents
121 out of 1 
 
Pharmaceutical Royalties, L.l.c.
 patent
131 out of 1 
 
Bioventure Investments, Kft
 patent
141 out of 41 
 
Bristol Meyers Squibb Company
 patents
151 out of 986 
 
Emory University
 patents
161 out of 31 
 
Genetic Systems Corporation
 patents
171 out of 36 
 
Bristol-myers Squibb
 patents
182 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2025

Loading Chart...
Loading Chart...
Loading Chart...
81 patents (USPTO):Explore Patents

Title: Innovations in Therapeutics: The Patented Works of Jeffrey A. Ledbetter

Introduction

Jeffrey A. Ledbetter, a prolific inventor located in Shoreline, WA, has made significant contributions to the field of biotechnology with a remarkable portfolio of 77 patents. His innovative work primarily focuses on the development of fusion polypeptides that hold promise for therapeutic applications.

Latest Patents

Among his latest patents, Ledbetter has disclosed compositions and methods related to paraoxonase fusion polypeptides. These innovations encompass bispecific molecules that include biologically active polypeptides linked to paraoxonase, thereby showcasing a versatile approach toward therapeutic solutions. Additionally, his patent on polynucleotides encoding ApoA-1 fusion polypeptides further highlights his multifaceted approach in combining different biological activities to enhance therapeutic efficacy.

Career Highlights

Throughout his career, Ledbetter has been associated with prominent companies such as Bristol-Myers Squibb Company and Emergent Product Development Seattle, LLC. His experience in these esteemed organizations has undoubtedly provided him invaluable insights into the pharmaceutical and biotechnological landscapes, enabling him to innovate effectively.

Collaborations

Ledbetter has collaborated with notable peers in the field, including Martha Susan Hayden-Ledbetter and William Brady. These collaborations have likely fostered a dynamic exchange of ideas, further enhancing his research endeavors and patent outputs.

Conclusion

In conclusion, Jeffrey A. Ledbetter stands out as a significant figure in the realm of biotechnology innovations. His extensive patent portfolio and collaborative efforts position him as a leader in developing novel therapeutic methods that could shape future healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…